# Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth

> **NCT02492841** · PHASE2,PHASE3 · COMPLETED · sponsor: **Universidad de los Andes, Chile** · enrollment: 169 (actual)

## Conditions studied

- Caries
- Dental Pulp Exposure

## Interventions

- **DRUG:** Mineral trioxide aggregate
- **DRUG:** Calcium hydroxide
- **DRUG:** Biodentine

## Key facts

- **NCT ID:** NCT02492841
- **Lead sponsor:** Universidad de los Andes, Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-08
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492841, "Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02492841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*